...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model
【24h】

Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model

机译:Gan-Lu-yin抑制鼠Wehi-3白血病细胞的增殖和迁移,BALB / C同种异体移植肿瘤模型中的肿瘤生长

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to explore the antitumor effect of Gan-Lu-Yin (GLY), a traditional Chinese herbal formula, on leukemia. Ethanolic extract of GLY was applied to evaluate its regulatory mechanisms in proliferation, migration, and differentiation of WEHI-3 leukemic cells as well as antitumor effect on BALB/c mice model. The results showed that GLY markedly reduced cell proliferation and migration with induced differentiation of WEHI-3 cells. The expression level of phosphorylated FAK, Akt, ERK1/2, and Rb was decreased p21 expression while level was increased in WEHI-3 treated with GLY. The results of cell cycle analysis revealed that GLY treatment could markedly induce Gl phase arrest and decrease cell population in S phase. Moreover, experimental results demonstrated that GLY decreased the protein expression and enzyme activity of MMP-2 and MMP-9. GLY treatment also reduced WEHI-3 leukemic infiltration in liver and spleen and tumor growth in animal model. Accordingly, GLY demonstrated an inhibitory effect on tumor growth with a regulatory mechanism partially through inhibiting FAK, Akt, and ERK expression in WEHI-3 cells. GLY may provide a promising antileukemic approach in the clinical application.
机译:本研究的目的是探讨Gan-Lu-yin(Gly),中草原,白血病的抗肿瘤效果。乙醇的乙醇提取物用于评估其对韦氏白血病细胞的增殖,迁移和分化的调节机制以及对BALB / C小鼠模型的抗肿瘤作用。结果表明,用诱导的韦氏-3细胞的细胞增殖和迁移显着降低了细胞增殖和迁移。磷酸化FAK,AKT,ERK1 / 2和RB的表达水平降低了P21表达,而在用过的韦氏处理的Wehi-3中增加了水平。细胞周期分析的结果显示,GLY治疗可显着诱导GL期捕捉和降低S期细胞群。此外,实验结果表明,大量降低了MMP-2和MMP-9的蛋白质表达和酶活性。 GLY治疗还降低了肝脏和脾脏的肺部血性渗透和动物模型中的肿瘤生长。因此,通过抑制FAK,AKT和Wehi-3细胞中的ERK表达,通常通过调节机制对肿瘤生长进行抑制作用。 Gly可以在临床应用中提供有前途的抗血糖方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号